Form 4: Cutera EVP, Chief Technology Officer, Michael Karavitis, Receives Option Repricing

Michael Karavitis, EVP and Chief Technology Officer of Cutera, Inc., had his stock options repriced to $1.54 per share on July 15, 2024.

Summary

• On July 15, 2024, Michael Karavitis, the EVP and Chief Technology Officer of Cutera, Inc., had his stock options repriced.
• The exercise price of his options was adjusted to $1.54 per share.
• The repricing affected multiple stock option grants with varying original exercise prices and vesting schedules.
• The total number of options repriced was 152,798.
• The vesting schedules for the options remain unchanged, contingent upon Karavitis' continued service with the company.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment depends on the investor's view of option repricing and the company's performance.

Positives

• The option repricing may incentivize Michael Karavitis to remain with the company and continue contributing to its success.
• The repricing aligns the executive's interests with those of the shareholders by providing a more achievable exercise price.

Negatives

• Option repricing can be viewed negatively by shareholders if it is perceived as rewarding underperformance.
• The repricing dilutes the value of existing shares if the options are eventually exercised.

Risks

• The value of the options is still subject to the volatility of Cutera's stock price.
• If Karavitis leaves the company before the options fully vest, a portion of the options may be forfeited.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Option repricing is a tool companies use to retain key employees, particularly in volatile market conditions. It is common in the tech industry to ensure that employee stock options remain valuable and serve as an incentive.

Comparison to Industry Standards

• Many companies in the technology and biotechnology sectors use stock options as a significant part of their compensation packages.
• Repricing of options is not uncommon, especially when a company's stock price has declined significantly.
• Companies like Novavax and Inovio Pharmaceuticals have also used option repricing to incentivize employees during periods of stock price decline.
• The specific terms of the repricing, such as the new exercise price and vesting schedule, are generally tailored to the individual executive and the company's specific circumstances.

Stakeholder Impact

• Shareholders may have mixed reactions depending on their views on executive compensation and the company's performance.
• Employees may view the repricing positively as it signals the company's commitment to retaining key talent.
• The repricing has no immediate impact on customers, suppliers, or creditors.

Key Dates

Keywords

Cutera, Karavitis, stock options, repricing, EVP, Chief Technology Officer, CUTR, executive compensation, vesting